Cargando…

Plasma proteome analysis of patients with type 1 diabetes with diabetic nephropathy

BACKGROUND: As part of a clinical proteomics program focused on diabetes and its complications we are looking for new and better protein biomarkers for diabetic nephropathy. The search for new and better biomarkers for diabetic nephropathy has, with a few exceptions, previously focused on either hyp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Overgaard, Anne Julie, Hansen, Henning Gram, Lajer, Maria, Pedersen, Lykke, Tarnow, Lise, Rossing, Peter, McGuire, James N, Pociot, Flemming
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2827395/ https://www.ncbi.nlm.nih.gov/pubmed/20205888 http://dx.doi.org/10.1186/1477-5956-8-4

Ejemplares similares

Quantitative iTRAQ-Based Proteomic Identification of Candidate Biomarkers for Diabetic Nephropathy in Plasma of Type 1 Diabetic Patients
por: Overgaard, Anne Julie, et al.
Publicado: (2010)

Plasma Growth Differentiation Factor-15 Independently Predicts All-Cause and Cardiovascular Mortality As Well As Deterioration of Kidney Function in Type 1 Diabetic Patients With Nephropathy
por: Lajer, Maria, et al.
Publicado: (2010)

Osteoprotegerin and Mortality in Type 2 Diabetic Patients
por: Reinhard, Henrik, et al.
Publicado: (2010)

Serum Uric Acid as a Predictor for Development of Diabetic Nephropathy in Type 1 Diabetes: An Inception Cohort Study
por: Hovind, Peter, et al.
Publicado: (2009)

The CTGF -945GC polymorphism is not associated with plasma CTGF and does not predict nephropathy or outcome in type 1 diabetes
por: Dendooven, Amélie, et al.
Publicado: (2011)

Tubular and Glomerular Injury in Diabetes and the Impact of ACE Inhibition
por: Nielsen, Stine E., et al.
Publicado: (2009)

Plasma lipid species at type 1 diabetes onset predict residual beta-cell function after 6 months
por: Overgaard, Anne Julie, et al.
Publicado: (2018)

Characterization of plasma lipidomics in adolescent subjects with increased risk for type 1 diabetes in the DiPiS cohort
por: Andersson Svärd, Agnes, et al.
Publicado: (2020)

Systemic TNFα correlates with residual β-cell function in children and adolescents newly diagnosed with type 1 diabetes
por: Overgaard, Anne Julie, et al.
Publicado: (2020)

Urinary Proteomics for Early Diagnosis in Diabetic Nephropathy
por: Zürbig, Petra, et al.
Publicado: (2012)

Vitamin D Levels and Mortality in Type 2 Diabetes
por: Joergensen, Christel, et al.
Publicado: (2010)

High Neonatal Blood Iron Content Is Associated with the Risk of Childhood Type 1 Diabetes Mellitus
por: Kyvsgaard, Julie Nyholm, et al.
Publicado: (2017)

Independent component and pathway-based analysis of miRNA-regulated gene expression in a model of type 1 diabetes
por: Bang-Berthelsen, Claus H, et al.
Publicado: (2011)

A Dual Systems Genetics Approach Identifies Common Genes, Networks, and Pathways for Type 1 and 2 Diabetes in Human Islets
por: Kaur, Simranjeet, et al.
Publicado: (2021)

Multicentric Validation of Proteomic Biomarkers in Urine Specific for Diabetic Nephropathy
por: Alkhalaf, Alaa, et al.
Publicado: (2010)

Proteome Analysis—A Novel Approach to Understand the Pathogenesis of Type 1 Diabetes Mellitus
por: Karlsen, Allan E., et al.
Publicado: (2001)

Type 1 diabetes genome-wide association studies: not to be lost in translation
por: Pociot, Flemming
Publicado: (2017)

Genetic risk factors affecting mitochondrial function are associated with kidney disease in people with Type 1 diabetes
por: Swan, E J, et al.
Publicado: (2015)

YKL-40, a Marker of Inflammation and Endothelial Dysfunction, Is Elevated in Patients With Type 1 Diabetes and Increases With Levels of Albuminuria
por: Rathcke, Camilla Noelle, et al.
Publicado: (2009)

Lipidomic and metabolomic characterization of a genetically modified mouse model of the early stages of human type 1 diabetes pathogenesis
por: Overgaard, Anne Julie, et al.
Publicado: (2015)

Cardiovascular autonomic neuropathy and the impact on progression of diabetic kidney disease in type 1 diabetes
por: Bjerre-Christensen, Theis, et al.
Publicado: (2021)

The Type 1 Diabetes - HLA Susceptibility Interactome - Identification of HLA Genotype-Specific Disease Genes for Type 1 Diabetes
por: Brorsson, Caroline, et al.
Publicado: (2010)

Urinary Alpha- and Pi-Glutathione S-Transferases in Adult Patients with Type 1 Diabetes
por: von Scholten, Bernt Johan, et al.
Publicado: (2014)

Arterial Stiffness Is Associated With Cardiovascular, Renal, Retinal, and Autonomic Disease in Type 1 Diabetes
por: Theilade, Simone, et al.
Publicado: (2013)

Shared Genetic Basis for Type 1 Diabetes, Islet Autoantibodies, and Autoantibodies Associated With Other Immune-Mediated Diseases in Families With Type 1 Diabetes
por: Brorsson, Caroline A., et al.
Publicado: (2015)

Elevated Urinary Connective Tissue Growth Factor in Diabetic Nephropathy Is Caused by Local Production and Tubular Dysfunction
por: Gerritsen, Karin G. F., et al.
Publicado: (2015)

Faecal biomarkers in type 1 diabetes with and without diabetic nephropathy
por: Winther, Signe Abitz, et al.
Publicado: (2021)

Alu Elements as Novel Regulators of Gene Expression in Type 1 Diabetes Susceptibility Genes?
por: Kaur, Simranjeet, et al.
Publicado: (2015)

Novel Susceptibility Locus at 22q11 for Diabetic Nephropathy in Type 1 Diabetes
por: Wessman, Maija, et al.
Publicado: (2011)

N-glycosylation proteome enrichment analysis in kidney reveals differences between diabetic mouse models
por: Liljedahl, Leena, et al.
Publicado: (2016)

The impact of the glucagon‐like peptide 1 receptor agonist liraglutide on the streptozotocin‐induced diabetic mouse kidney proteome
por: Liljedahl, Leena, et al.
Publicado: (2019)

Type 1 Diabetes Candidate Genes Linked to Pancreatic Islet Cell Inflammation and Beta-Cell Apoptosis
por: Størling, Joachim, et al.
Publicado: (2017)

Precision diagnostic approach to predict 5-year risk for microvascular complications in type 1 diabetes
por: Al-Sari, Naba, et al.
Publicado: (2022)

Urinary and plasma proteomics to discover biomarkers for diagnosing between diabetic nephropathy and minimal change nephrotic syndrome or membranous nephropathy
por: Araumi, Akira, et al.
Publicado: (2021)

Proteomic and bioinformatic discovery of biomarkers for diabetic nephropathy
por: Thippakorn, Chadinee, et al.
Publicado: (2018)

Higher Plasma Levels of Advanced Glycation End Products Are Associated With Incident Cardiovascular Disease and All-Cause Mortality in Type 1 Diabetes: A 12-year follow-up study
por: Nin, Johanna W., et al.
Publicado: (2011)

Low-grade inflammation in type 2 diabetes: a cross-sectional study from a Danish diabetes outpatient clinic
por: Okdahl, Tina, et al.
Publicado: (2022)

iTRAQ plasma proteomics analysis for candidate biomarkers of type 2 incipient diabetic nephropathy
por: Lu, Hongmei, et al.
Publicado: (2019)

Children at onset of type 1 diabetes show altered N-glycosylation of plasma proteins and IgG
por: Rudman, Najda, et al.
Publicado: (2022)

Can ADAMTS13 Lead Us to the Paradise of Personalized Medicine?
por: Rossing, Peter, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_euedsp3qlqjhf40krqi5948jsu